Blackstone

Blackstone’s Strategic Move in Japan’s Pharmaceutical Sector: A Game-Changer for Clinical Trials

In a significant move that underscores the growing interest of global private equity firms in Japan’s life sciences industry, Blackstone Inc. has announced its acquisition of a majority stake in CMIC Co., a Tokyo-based contract research organization (CRO). The deal,...